2-chloroadenosine has been researched along with Enlarged Spleen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dann, EJ; Polliack, A | 1 |
Birtolo, S; Bocchia, M; Forconi, F; Lauria, F; Marotta, G; Raspadori, D; Rondelli, D; Salvucci, M; Tura, S; Ventura, MA; Zinzani, PL | 1 |
1 trial(s) available for 2-chloroadenosine and Enlarged Spleen
Article | Year |
---|---|
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Bone Marrow; Deoxyadenosines; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Splenomegaly; Survival Rate; Time Factors | 1997 |
1 other study(ies) available for 2-chloroadenosine and Enlarged Spleen
Article | Year |
---|---|
Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL?
Topics: 2-Chloroadenosine; Aged; Bone Marrow; Female; Humans; Leukemia, Hairy Cell; Neoplasm Recurrence, Local; Remission Induction; Splenomegaly | 1994 |